End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.44 CNY | +0.12% | -1.97% | +11.72% |
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
Weaknesses
- The company appears highly valued given the size of its balance sheet.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.72% | 936M | - | ||
+0.73% | 101B | A- | ||
-11.98% | 58.77B | A- | ||
+75.71% | 47.81B | B | ||
+5.26% | 35.9B | B | ||
+4.37% | 18.77B | B- | ||
+17.33% | 16.92B | C+ | ||
+5.92% | 13.49B | B- | ||
-6.67% | 12.88B | B | ||
-25.86% | 11.93B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300848 Stock
- Ratings Miracll Chemicals Co.,Ltd